Search - Leibniz Institute for Prevention Research and Epidemiology

211. [BIPS Project] PAS-study for upadacitinib

URL: /en/research/projects/detail-view.html?projID=1058&cHash=7c786a506c59206d88343acad19a145c
Date: 15-02-23

Upadacitinib (Rinvoq®) is a so-called Januskinase (JAK)-inhibitor which is approved for the treatment of chronic rheumatic diseases such as ulcerative colitis, rheumatic arthritis and atopic…

212. [BIPS Project] Standards and tools for data monitoring in observational studies

URL: /en/research/projects/detail-view.html?projID=991&cHash=b7d599d70fdcd19b5e3163055c677bfe
Date: 01-02-23

Our objective is to further the widespread conduct of harmonised data quality assessments in observational health research by extending the cross-disciplinary scope and the methods of our data…

213. Hajo Zeeb appointed deputy chairman of the Radiation Protection Commission

URL: /en/media/press/single-view/hajo-zeeb-zum-stellvertretenden-vorsitzenden-der-strahlenschutzkommission-berufen.html
Date: 26-01-23

Prof. Dr. Hajo Zeeb has been a member of the Radiation Protection Commission (SSK) since 2021. He heads the Department of Prevention and Evaluation at the Leibniz Institute for Prevention Research…

214. Achievements of our work

URL: /en/methodological-competence-platform/achievements-of-our-work.html
Date: 23-01-23

Achievements of our work Roadmap to harmonisation An inventory of current surveillance systems for diet, physical activity and sedentary behaviour was developed to…

215. Pharmacoepidemiology in Vulnerable Groups

URL: /en/the-institute/departments/clinical-epidemiology/pharmacoepidemiology-in-vulnerable-groups.html
Date: 17-01-23

Research Infrastructures GePaRD Bremen Cancer Registry Bremen Mortality Index Ulrike Haug Temp. Head Contact: Prof. Dr. Ulrike Haug Tel: +49 (0)421 218-56862 Fax: +49 (0)421…

216. Selected publications in January

URL: /en/media/news/single-view/ausgewaehlte-publikationen-im-januar.html
Date: 12-01-23

How harmful is it to your health to live on a major road? Are info-mails from research institutes to stakeholders actually read? And: How must health policy be made so that plans for a healthier…

217. Monitoring of Drug Utilization and Safety

URL: /en/the-institute/departments/clinical-epidemiology/monitoring-of-drug-utilization-and-safety.html
Date: 10-01-23

More units Translational Cancer Epidemiology Pharmacoepidemiology in Vulnerable Groups Research infrastructures GePaRD Bremen Cancer Registry Bremen Mortality Index Jonas Reinold …

218. [BIPS Project] Cross-departmental Center B: Data Science

URL: /en/research/projects/detail-view.html?projID=1050&cHash=a9415eb322a6d9898bb99d8ac02946bd
Date: 01-01-23

High quality research data are essential for epidemiological research. Generally, it is not possible to fully exploit the potential of the research data generated in individual research projects…

219. [BIPS Project] Cross-departmental Center A: Research Data Infrastructure

URL: /en/research/projects/detail-view.html?projID=1049&cHash=a7588da6ccc395c3d3f81ba0c490fec4
Date: 01-01-23

High quality research data are essential for epidemiological research. Generally, it is not possible to fully exploit the potential of the research data generated in individual research projects…

220. [BIPS Project] PAS-study for tralokinumab

URL: /en/research/projects/detail-view.html?projID=1040&cHash=61d281ea60f3f02b443b69dfb3b9577a
Date: 01-01-23

PAS-study of tralokinumab use in pregnancy Tralokinumab is a biological agent developed for the treatment of moderate to severe atopic dermatitis (AD) and is administered by subcutaneous…